Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.2616
-0.0184 (-6.57%)
At close: Jun 2, 2026, 4:00 PM EDT
0.2620
+0.0004 (0.15%)
Pre-market: Jun 3, 2026, 7:44 AM EDT

Ensysce Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.754.313.51.123.1512.26
Cash & Short-Term Investments
0.754.313.51.123.1512.26
Cash Growth
-75.58%23.08%211.68%-64.30%-74.33%6215.04%
Accounts Receivable
-0.420.120.10.280.44
Other Current Assets
1.262.511.721.071.852.93
Total Current Assets
2.017.245.342.295.315.66
Net Property, Plant & Equipment
0.120.12--0.030.78
Other Long-Term Assets
0.040.090.250.420.59-
Total Assets
2.177.455.62.715.8916.42
Accounts Payable
1.613.271.361.942.940.3
Accrued Expenses
0.980.990.550.542.233.41
Short-Term Debt
0.250.310.30.854.2712.75
Current Portion of Leases
----0.030.02
Total Current Liabilities
2.844.572.213.339.4616.48
Long-Term Debt
----0.144.44
Other Long-Term Liabilities
--0.010.030.313.65
Total Long-Term Liabilities
--0.010.030.458.09
Total Liabilities
2.844.572.223.369.9124.58
Common Stock
000000
Additional Paid-in Capital
142.94142.93133.25121.23107.2277.97
Retained Earnings
-143.28-139.72-129.54-121.56-110.93-85.85
Total Common Shareholders' Equity
-0.343.213.71-0.32-3.71-7.88
Minority Interest
--0.33-0.33-0.33-0.32-0.28
Shareholders' Equity
-0.342.883.38-0.65-4.03-8.16
Total Liabilities & Equity
2.57.455.62.715.8916.42
Total Debt
0.250.310.30.854.4317.21
Net Cash (Debt)
0.543.20.27-1.29-4.95
Net Cash Growth
-87.52%25.10%1090.16%---
Net Cash Per Share
0.131.574.591.78-107.24-883.60
Book Value
-0.343.213.71-0.32-3.71-7.88
Book Value Per Share
-0.091.265.32-2.14-309.67-1406.53
Tangible Book Value
-0.343.213.71-0.32-3.71-7.88
Tangible Book Value Per Share
-0.091.265.32-2.14-309.67-1406.53
SEC Filings: 10-K · 10-Q